The COVID-19 pandemic brought to light some pharmaceutical monopolies. In particular, the desperately needed surgical and N-95 masks were primarily manufactured in China. As the Coronavirus began to spread around the globe, the Chinese government decided to keep the masks they made for their own population. This caused a shortage of masks around the world (Bradsher 2020).